结肠癌术后复发的研究进展

Colon cancer is one of the most common cancers in China,with an increasing incidence these years.Currently,the combined therapy based on radical surgery has dramatically improved the survival rate and life quality of patients,however,a large percentage of patients still died of recurrence and metastasis.In recent years,the treatment strategies for the recurrence of colon cancer have been greatly advanced,especially the new targeted drugs and chemotherapeutic drugs,which lead to a significantly improved therapeutic efficacy and a better life quality.Therefore,how to choose and use these new treatments synthetically and reasonably become a great challenge to all surgeons,especially to digestive surgeons.